The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion

Abstract The role of estrogen as a neurotrophic/neuroprotective agent in neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases is increasingly being shown. In this study we examine the neuroprotective effects of β-estradiol on SHSY5Y neuroblastoma cells which have been exposed to the heavy metals cobalt and mercury. The results show that cobalt and mercury are able to induce oxidative stress and cell cytotoxicity and increase the secretion of β-amyloid 1–40 and 1–42. These deleterious effects are reversed by the pretreatment of cells with β-estradiol. It is further shown that β-estradiol exerts its neuroprotective action through mechanisms which reduce oxidative stress and reduce β-amyloid secretion. Pre-treatment of the cells with α-estradiol did not alleviate the toxic effects of the heavy metals. Our results are significant as they contribute to a better understanding of the mode of action of estrogen with relevance to its use in the treatment of neurodegenerative disorders.

[1]  M. Marino,et al.  Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. , 1998, Biochemical and biophysical research communications.

[2]  D. Selkoe,et al.  Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. , 1994, Annual review of cell biology.

[3]  M. Toborek,et al.  Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. , 1994, The American journal of clinical nutrition.

[4]  P. Murphy,et al.  Role of calcium in prolactin-stimulated c-myc gene expression and mitogenesis in Nb2 lymphoma cells. , 1988, Endocrinology.

[5]  Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. , 1998, Molecular endocrinology.

[6]  Roger M. Nitsch,et al.  Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) , 1996, The Journal of Biological Chemistry.

[7]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[8]  C. Hess,et al.  Melatonin protects SHSY5Y neuroblastoma cells from cobalt‐induced oxidative stress, neurotoxicity and increased β‐amyloid secretion , 2001, Journal of pineal research.

[9]  R. Epand,et al.  Mechanism of activation of protein kinase C: roles of diolein and phosphatidylserine. , 1993, Biochemistry.

[10]  P. Shughrue,et al.  Estradiol Modulates bcl-2 in Cerebral Ischemia: A Potential Role for Estrogen Receptors , 1999, The Journal of Neuroscience.

[11]  H. Daron,et al.  The inactivation of thymidylate synthase by periodate. , 1984, Journal of inorganic biochemistry.

[12]  R. L. Moss,et al.  Rapid Action of 17β-Estradiol on Kainate-Induced Currents in Hippocampal Neurons Lacking Intracellular Estrogen Receptors. , 1999, Endocrinology.

[13]  J. Growdon,et al.  Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. , 1993, The Journal of biological chemistry.

[14]  J. Simpkins,et al.  Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione , 1998, Neuroscience.

[15]  R. Curi,et al.  Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[16]  T. Burrage,et al.  Hormonal induction of secretory granules in a pituitary tumor cell line. , 1986, Endocrinology.

[17]  J. M. Palma,et al.  Metabolism of oxygen radicals in peroxisomes and cellular implications. , 1992, Free radical biology & medicine.

[18]  Gene regulation by steroid hormones , 1989, Cell.

[19]  P. R. Yallapragada,et al.  Modulation of protein kinase C by heavy metals. , 1995, Toxicology letters.

[20]  C. Pike,et al.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.

[21]  B. Weiss,et al.  Food additives as a source of behavioral disturbances in children. , 1986, Neurotoxicology.

[22]  J. Simpkins,et al.  Estrogens and Estrogen‐Like Non‐Feminizing Compounds: Their Role in the Prevention and Treatment of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[23]  R. Brinton,et al.  17 β-Estradiol Enhances the Outgrowth and Survival of Neocortical Neurons in Culture , 1997, Neurochemical Research.

[24]  A. LeBlanc,et al.  Testosterone‐mediated neuroprotection through the androgen receptor in human primary neurons , 2001, Journal of neurochemistry.

[25]  R. Cornelius,et al.  Cobalt(III)-promoted hydrolysis of atp , 1984 .

[26]  W. D. Ehmann,et al.  Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.

[27]  T. Morgan,et al.  Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease , 1998, The Journal of Neuroscience.

[28]  C. Behl,et al.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Williams,et al.  Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. , 1982, Journal of steroid biochemistry.

[30]  P. Wise,et al.  Constitutive and regulated prolactin secretion: effects of estradiol. , 1994, Biology of reproduction.

[31]  V. Henderson.  Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer’s Disease , 1997 .

[32]  G. Benzi,et al.  Are reactive oxygen species involved in Alzheimer's disease? , 1995, Neurobiology of Aging.

[33]  J. Growdon,et al.  Increased blood mercury levels in patients with Alzheimer's disease , 1998, Journal of Neural Transmission.

[34]  K. Davies,et al.  Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. , 1991, Gerontology.

[35]  M. Mattson,et al.  Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium , 1995, Brain Research.

[36]  Effect of melatonin, piperonyl butoxide, or cobalt chloride on L-cysteine-induced lipid peroxidation in homogenate from whole brain of mice. , 1996, Toxicology letters.

[37]  B. Katzenellenbogen,et al.  Uterine plasminogen activator activity: modulation by steroid hormones. , 1982, Endocrinology.

[38]  F. Holsboer,et al.  17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. , 1995, Biochemical and biophysical research communications.

[39]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[40]  V. Henderson.  Estrogen, cognition, and a woman's risk of Alzheimer's disease. , 1997, The American journal of medicine.

[41]  A. Edström,et al.  Inhibition and stimulation of rapid axonal transport In Vitro by sulfhydryl blockers , 1976, Brain Research.

[42]  C. Shaw,et al.  Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.

[43]  R. Martins,et al.  Chemical andropause and amyloid-beta peptide. , 2001, JAMA.

[44]  P. Greengard,et al.  Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides , 1998, Nature Medicine.

[45]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[46]  M. Murakoshi,et al.  Regulation of prostatic glutathione-peroxidase (GSH-PO) in rats treated with a combination of testosterone and 17 beta-estradiol. , 1999, The Journal of toxicological sciences.

[47]  F. Holsboer,et al.  Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.

[48]  W. D. Ehmann,et al.  Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.

[49]  D. Dorsa,et al.  Transcriptional Effects of Estrogen on Neuronal Neurotensin Gene Expression Involve cAMP/Protein Kinase A-Dependent Signaling Mechanisms , 1998, The Journal of Neuroscience.

[50]  B. Sherwin.  Estrogen effects on cognition in menopausal women , 1997, Neurology.

[51]  S. Austad,et al.  Genetic analysis of ageing: role of oxidative damage and environmental stresses , 1996, Nature Genetics.

[52]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[53]  S. Paul,et al.  Sodium Salicylate and 17β‐Estradiol Attenuate Nuclear Transcription Factor NF‐κB Translocation in Cultured Rat Astroglial Cultures Following Exposure to Amyloid Aβ1‐40 and Lipoplysaccharides , 1999 .

[54]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Hock,et al.  Mercury Induces Cell Cytotoxicity and Oxidative Stress and Increases β‐Amyloid Secretion and Tau Phosphorylation in SHSY5Y Neuroblastoma Cells , 2000, Journal of neurochemistry.

[56]  H. Stähelin,et al.  N‐Acetyl‐l‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation , 2001, Journal of neurochemistry.

[57]  M. Mattson,et al.  Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. , 1997, Neuroreport.

[58]  W. D. Ehmann,et al.  Regional brain trace-element studies in Alzheimer's disease. , 1988, Neurotoxicology.

[59]  Yun-Lian Lin,et al.  The Neuroprotective Effects of Phytoestrogens on Amyloid β Protein-induced Toxicity Are Mediated by Abrogating the Activation of Caspase Cascade in Rat Cortical Neurons* , 2001, The Journal of Biological Chemistry.

[60]  S. Korenman.  Comparative binding affinity of estrogens and its relation to estrogenic potency. , 1969, Steroids.

[61]  D. Lubahn,et al.  Electrophoretic characterization of purified bovine, porcine, murine, rat, and human uterine estrogen receptors. , 1985, The Journal of biological chemistry.

[62]  J. Simpkins,et al.  Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. , 1997, The American journal of medicine.